版本:
中国

BRIEF-Sonoma Pharmaceuticals announces results from Sebuderm Gel study in treatment of Seborrheic Dermatitis

March 16 Sonoma Pharmaceuticals Inc

* Sonoma Pharmaceuticals announces results from Sebuderm™ gel study in treatment of Seborrheic Dermatitis

* IGA of efficacy improvement from baseline was 33% at day 14 and 52% at day 28 for the study Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐